About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- Adults with obesity, without type 2 diabetes
- Sample size
- 751 randomised 1:1
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Sponsor-funded (Eli Lilly). Open-label design. Head-to-head comparison with another company's medicine.
Cited in
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.